Session?11?: Early MS?3
| O25 | Deficient responses of blood mononuclear cells to IFN-b in vitro: implications for IFN-b treatment of MS |
| O26 | Pharmacogenomics in multiple sclerosis: relevance to interferon-b 1a therapy |
CONGRES ECTRIMS
6 - 9 septembre 2000
Toulouse
|
Retour au sommaire |